NEW YORK, April 29 (GenomeWeb News) - Shimadzu and the Institute of Medical Science at the University of Tokyo plan to jointly conduct genomic and proteomic analyses with the goal of identifying new disease-related genes and biomarkers.
Already have a GenomeWeb or 360Dx account?Login Now.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.